Sophysa

Sophysa started operations in 1976 in France, and set a significant milestone in 1985 with the introduction of the world’s first programmable valve Sophy. This represented a major advance in the treatment of hydrocephalus. The development of the Sophy valve has contributed to the improvement of surgical management by allowing neurosurgeons to modify the operating pressure of the valve through the skin, and adapt it to the precise clinical needs of each patient. This reduces the number of surgical reoperations and allows patients a greater chance of full recovery without the need for invasive, secondary surgery. Sophysa is committed to combine sustainable growth with innovation and creativity to provide high-quality solutions, expertly made in France, and used all over the world.